From nutrition counseling and classes to long-term lifestyle planning, to meal replacement programs and support groups, we help you stay on track for the long haul, even if you stop taking GLP-1 medications
Semaglutide once a week in adults with overweight or obesity, with or without type 2 diabetes in an east Asian population (step 6): A randomised, double-blind, double-dummy, placebo-controlled, phase 3a trial
Well examine your hair health under a microscope and create a customized maintenance plan that includes light therapy and specialized products to keep your hair thick, full, and vibrant
In clinical trials, patients using Semaglutide have shown an average weight loss of 15-18%, while Tirzepatide has demonstrated up to 20-22% weight loss in some cases